Related Research Articles
Guy Goodwin is a senior research fellow and until recently was the W.A. Handley Professor of Psychiatry at the University of Oxford (2014). A fellow of the Academy of Medical Sciences, Goodwin has served as principal investigator in many clinical trials for the treatment of bipolar disorder. He is also an Emeritus Senior Investigator at the National Institute for Health and Care Research (NIHR) and has been on the advisory boards of numerous research councils. He was President of the European College of Neuropsychopharmacology from 2013 to 2016.
Bankole A. Johnson, DSc, MD, MPhil, FRCPsych is a Nigerian psychiatrist. He served as Alumni Professor and Chairman of the Department of Psychiatry and Neurobehavioral Sciences at the University of Virginia and is known for his research into addiction.
Herbert David Kleber was an American psychiatrist and substance abuse researcher. His career, centered on the evidence-based treatment of addiction, focused on scientific approaches in place of punishment and moralisms. His career focused on pathology of addiction to help patients reduce the severe discomforts of withdrawal, avoid relapse and stay in recovery.
David John Nutt is an English neuropsychopharmacologist specialising in the research of drugs that affect the brain and conditions such as addiction, anxiety, and sleep. He is the chairman of Drug Science, a non-profit which he founded in 2010 to provide independent, evidence-based information on drugs. Until 2009, he was a professor at the University of Bristol heading their Psychopharmacology Unit. Since then he has been the Edmond J Safra chair in Neuropsychopharmacology at Imperial College London and director of the Neuropsychopharmacology Unit in the Division of Brain Sciences there. Nutt was a member of the Committee on Safety of Medicines, and was President of the European College of Neuropsychopharmacology.
Jules Angst is a Swiss academic who is Emeritus Professor of Psychiatry at Zurich University in Zurich, Switzerland, and Honorary Doctor of Heidelberg University in Heidelberg, Germany.
DrugScience or Drug Science (originally called the Independent Scientific Committee on Drugs (ISCD)) is a UK-based drugs advisory committee proposed and initially funded by hedge fund manager Toby Jackson. It is chaired by Professor David Nutt and was officially launched on 15 January 2010 with the help of the Centre for Crime and Justice Studies. The primary aim of the committee is to review and investigate the scientific evidence of drug harms without the political interference that could result from government affiliation.
The European College of Neuropsychopharmacology (ECNP) is a pan-European, non-profit scientific association that serves as a platform to exchange and promote research in the field of neuropsychopharmacology. The ECNP “is committed to ensuring that advances in the understanding of brain function and human behaviour are translated into better treatments and enhanced public health”. The ECNP organises a number of activities to achieve this aim, such as a yearly congress, workshops, seminars, New Frontiers Meetings, publications, awards, supported talks and much more.
Celso Arango is a psychiatrist who has worked as a clinician, researcher, and educator in psychiatry and mental health, notably in the field of child and adolescent psychiatry, psychosis, and mental health promotion.
Charles P. O'Brien is a research scientist, medical educator and a leading expert in the science and treatment of addiction. He is board certified in neurology, psychiatry and addiction psychiatry. He is currently the Kenneth E. Appel Professor of Psychiatry, and vice chair of psychiatry, in the Perelman School of Medicine at the University of Pennsylvania.
Eduard Vieta Pascual is a Spanish psychiatrist and a leading scientific authority on the neurobiology and treatment of bipolar disorder.
Mark J. Millan is a neuroscientist specialising in the study and improved treatment of disorders of brain. He was the Director of Pharmacological Innovation for the Central Nervous System (CNS) at the Institute de Recherché de Servier (IDRS) in Paris, France. He is also the Secretary of the European College of Neuropsychopharmacology. Currently he is a Visiting Professor in the School of Psychology and Neuroscience at Glasgow University. Born in Edinburgh, Scotland, he is the son of former Scottish Labour Party Leader and European Commissioner, Bruce Millan, studied at Cambridge University and then spent ten years at the Max Planck Institut fur Psychiatrie, Munich, before moving to Paris.
Gil Zalsman is an Israeli psychiatrist and child psychiatrist, the Director of the Geha Mental Health Center, Petach Tikva, Israel, where he also heads the Adolescent Day Unit.
Martien J.H. Kas is associate professor in the Department of Translational Neuroscience, Brain Center Rudolf Magnus, at the University Medical Center Utrecht, where he leads a work group entitled "Translational Behavioral Genetics" that researches cross-species behavioral genetics to better understand origins and develop treatments for psychiatric disorders.
Joseph Zohar the Director of the National Post-Trauma Center, Research Foundation by the Sheba Medical Center in Tel HaShomer and an emeritus professor of psychiatry at the Faculty of Medicine, at Tel Aviv University, Israel at Tel Aviv University.
Elisabeth Binder is a medical doctor and neuroscientist specializing in the study of mood and anxiety disorders. She is the director of the Department of Translational Research of the Max Planck Institute of Psychiatry in Munich, Germany. In addition to research, she is a member of the executive committee of the European College of Neuropsychopharmacology (ECNP).
Laurence Lanfumey-Mongredien is a neuroscientist specializing in preclinical research in neuroscience and molecular neuropsychopharmacology. Based at INSERM, she is the team leader of the “Pathophysiology of anxio-depressive and addictive disorders” research group. She is also a member of many scientific communities, most notably serving as a councilor on the executive committee of the European College of Neuropsychopharmacology.
Stephen Michael Stahl is an author and professor of psychiatry with expertise in psychopharmacology. He is currently a professor at the University of California, San Diego, and serves as Honorary Fellow in psychiatry department at the University of Cambridge. He is also the chairman of Neuroscience Education Institute (NEI) and Arbor Scientia Group.
Walter Wolfgang Fleischhacker is an Austrian psychiatrist and psychotherapist. Previously professor of psychiatry at the Medical University Innsbruck, he was appointed president of the university 1 October 2017.
René Sylvain Kahn is a neuropsychiatrist and the Esther and Joseph Klingenstein Professor and System Chair of Psychiatry at the Icahn School of Medicine at Mount Sinai in the United States, a position he has held since 2017. He previously served as Professor of Psychiatry and Director of the Brain Center Rudolf Magnus at the University Medical Center Utrecht in the Netherlands. Kahn is recognized for his research on the neurobiology of schizophrenia. He served as a former president of the Schizophrenia International Research Society and was elected to the Royal Netherlands Academy of Arts and Sciences in 2009. He received the Neuropsychopharmacology Award from the European College of Neuropsychopharmacology in 2014.
Herman Meïr van Praag is a Dutch psychiatrist. He was a professor of psychiatry at the University of Groningen, Utrecht University, Albert Einstein College of Medicine and Maastricht University. Van Praag is considered the founder of biological psychiatry in the Netherlands. After his retirement, he has written extensively on religiosity.
References
- ↑ Prof. dr. W. van den Brink, 1952 - at the UvA Album Academicum website.
- 1 2 "Prof. dr. W. van den Brink MD". www.amc.nl. Retrieved 6 July 2015.
- 1 2 "Van den Brink Group – Addiction". www.amcpsychiatrie.nl. Retrieved 6 July 2015.
- ↑ "The Executive Committee". www.ecnp.eu. Retrieved 6 July 2015.
- ↑ "Wim van den Brink". www.lebic-amc.nl. Retrieved 6 July 2015.
- ↑ Yan, Jun (6 February 2009). "Heroin-Assisted Treatment Helps Some Patients". Psychiatric News. 44 (3): 16. doi:10.1176/pn.44.3.0016.
- 1 2 3 4 5 6 7 "Wim van den Brink, MD PhD" (PDF). www.ecnp.eu. Retrieved 6 July 2015.
